Evaluating a New International Risk-Prediction Tool in IgA Nephropathy

IMPORTANCE: Although IgA nephropathy (IgAN) is the most common glomerulonephritis in the world, there is no validated tool to predict disease progression. This limits patient-specific risk stratification and treatment decisions, clinical trial recruitment, and biomarker validation. OBJECTIVE: To der...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Intern Med
Autores principales: Barbour, Sean J., Coppo, Rosanna, Zhang, Hong, Liu, Zhi-Hong, Suzuki, Yusuke, Matsuzaki, Keiichi, Katafuchi, Ritsuko, Er, Lee, Espino-Hernandez, Gabriela, Kim, S. Joseph, Reich, Heather N., Feehally, John, Cattran, Daniel C.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583088/
https://ncbi.nlm.nih.gov/pubmed/30980653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2019.0600
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares